Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

NEW YORK, July 7, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global mRNA ...

When the COVID-19 pandemic swept across the world in 2020, the mRNA vaccines came to the rescue of many people—but in the ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

Conducts 27% Workforce Reduction, Ceases Operations at Applied DNA Clinical Labs, Positions LineaRx for Growth – STONY BROOK, ...

Advancements in manufacturing technologies is a key driver driving nucleic acid therapeutics CDMO market revenue growth.

In a step toward treating mitochondrial diseases, researchers in the Netherlands have successfully edited harmful mutations ...

IMUNON announces promising Phase 1 results for IMNN-101, a DNA plasmid vaccine demonstrating enhanced durability and potential advantages over mRNA vaccines. Quiver AI Summary IMUNON, Inc., a ...

Researchers from the University of Sydney have developed a system that mimics natural selection inside living mammalian cells ...